BlackRock Institutional Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$73.2M	Buy	1,953,854 +51,511	+3%	+$2.16M	0.01%	1111
2016 Q3	$129M	Sell	1,902,343 -23,987	-1%	-$1.69M	0.02%	748
2016 Q2	$107M	Buy	1,926,330 +149,671	+8%	+$9.43M	0.02%	814
2016 Q1	$112M	Buy	1,776,659 +3,770	+0.2%	+$251K	0.02%	781
2015 Q4	$167M	Buy	1,772,889 +11,275	+0.6%	+$1.05M	0.03%	616
2015 Q3	$142M	Buy	1,761,614 +9,049	+0.5%	+$1.01M	0.02%	663
2015 Q2	$210M	Sell	1,752,565 -6,769	-0.4%	-$809K	0.03%	539
2015 Q1	$184M	Buy	1,759,334 +156,051	+10%	+$15.8M	0.03%	610
2014 Q4	$156M	Buy	1,603,283 +9,813	+0.6%	+$909K	0.02%	652
2014 Q3	$124M	Buy	1,593,470 +35,771	+2%	+$2.31M	0.02%	725
2014 Q2	$98.4M	Buy	1,557,699 +37,106	+2%	+$2.21M	0.02%	905
2014 Q1	$102M	Buy	1,520,593 +31,555	+2%	+$2.44M	0.02%	863
2013 Q4	$95.7M	Buy	1,489,038 +809	+0.1%	+$48.3K	0.02%	877
2013 Q3	$95.3M	Buy	1,488,229 +14,911	+1%	+$743K	0.02%	818
2013 Q2	$45.7M	Buy	+1,473,318	New	+$39.2M	0.01%	1214